DK320276A - Fremgangsmade til fremstilling af 2-substituerede oxazolpyridiner - Google Patents

Fremgangsmade til fremstilling af 2-substituerede oxazolpyridiner

Info

Publication number
DK320276A
DK320276A DK320276A DK320276A DK320276A DK 320276 A DK320276 A DK 320276A DK 320276 A DK320276 A DK 320276A DK 320276 A DK320276 A DK 320276A DK 320276 A DK320276 A DK 320276A
Authority
DK
Denmark
Prior art keywords
pyridines
procedure
preparation
substituted oxazole
oxazole
Prior art date
Application number
DK320276A
Other languages
Danish (da)
English (en)
Inventor
N P Jensen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK320276A publication Critical patent/DK320276A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/68Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
    • C07C63/72Polycyclic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK320276A 1975-07-29 1976-07-15 Fremgangsmade til fremstilling af 2-substituerede oxazolpyridiner DK320276A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/600,169 US4011326A (en) 1975-07-29 1975-07-29 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents

Publications (1)

Publication Number Publication Date
DK320276A true DK320276A (da) 1977-01-30

Family

ID=24402575

Family Applications (1)

Application Number Title Priority Date Filing Date
DK320276A DK320276A (da) 1975-07-29 1976-07-15 Fremgangsmade til fremstilling af 2-substituerede oxazolpyridiner

Country Status (14)

Country Link
US (1) US4011326A (enExample)
JP (1) JPS6037116B2 (enExample)
AU (1) AU505159B2 (enExample)
BE (1) BE844577A (enExample)
CH (1) CH603661A5 (enExample)
DE (1) DE2633905A1 (enExample)
DK (1) DK320276A (enExample)
ES (1) ES450245A1 (enExample)
FR (1) FR2319354A1 (enExample)
GB (1) GB1497985A (enExample)
HU (1) HU172167B (enExample)
NL (1) NL7607794A (enExample)
SE (1) SE431545B (enExample)
ZA (1) ZA764527B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085368Y2 (ja) * 1987-03-05 1996-02-14 日産自動車株式会社 内燃機関のコネクティングロッド
PT937075E (pt) * 1996-11-11 2004-05-31 Altana Pharma Ag Novas imidazo- e oxazolo-piridinas como inibidores da fosfodiesterese
ATE327753T1 (de) 2001-05-15 2006-06-15 Hoffmann La Roche Carbonsäure-substituierte oxazol-derivate zur verwendung als ppar-alpha und -gamma aktivatoren zur behandlung von diabetes
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
RU2295520C2 (ru) * 2002-07-03 2007-03-20 Ф.Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ ОКСАЗОЛА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ СЕНСИБИЛИЗАТОРОВ ИНСУЛИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АКТИВИРУЮЩИМ ДЕЙСТВИЕМ В ОТНОШЕНИИ PRARα И/ИЛИ PRARγ
EP1537091B1 (en) * 2002-08-30 2010-10-06 F. Hoffmann-La Roche AG Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
JP4286782B2 (ja) * 2002-09-12 2009-07-01 エフ.ホフマン−ラ ロシュ アーゲー 糖尿病の治療に有用な、pparアゴニストとしてのn−置換−1h−インドール−5−プロピオン酸化合物
RU2315767C2 (ru) * 2002-11-25 2008-01-27 Ф.Хоффманн-Ля Рош Аг Индолилпроизводные, способ их получения, фармацевтическая композиция, способ лечения и/или профилактики заболеваний
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白(rap)-缀合物对肝病症的治疗
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
CN110075069A (zh) 2009-05-06 2019-08-02 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935195A (en) * 1969-04-28 1976-01-27 Sterling Drug Inc. 4,4'-Stilbenebis-pyridooxazoles and related optical brighteners and polymeric compositions brightened thereby
FR2148362A1 (en) * 1971-08-11 1973-03-23 Ferlux 2-amino-(4,5-b)-oxazolopyridine cpds - with analgesic,anti-inflammato anticonvulsant,muscle relaxant and diuretic activity
AR208500A1 (es) * 1972-06-14 1977-02-15 Merck & Co Inc Procedimiento para la preparacion de derivados de oxazolo(4,5-b)-piridinas

Also Published As

Publication number Publication date
CH603661A5 (enExample) 1978-08-31
US4011326A (en) 1977-03-08
SE7608037L (sv) 1977-01-30
DE2633905A1 (de) 1977-02-17
ES450245A1 (es) 1979-05-16
NL7607794A (nl) 1977-02-01
SE431545B (sv) 1984-02-13
JPS6037116B2 (ja) 1985-08-24
AU505159B2 (en) 1979-11-08
HU172167B (hu) 1978-06-28
JPS5217495A (en) 1977-02-09
FR2319354B1 (enExample) 1979-07-20
GB1497985A (en) 1978-01-12
BE844577A (fr) 1977-01-28
AU1605276A (en) 1978-01-26
ZA764527B (en) 1978-03-29
FR2319354A1 (fr) 1977-02-25

Similar Documents

Publication Publication Date Title
DK148907C (da) Analogifremgangsmaade til fremstilling af dihydrocyclosporin c
DK149107C (da) Analogifremgangsmaade til fremstilling af quinazolonderivater
DK151013C (da) Analogifremgangsmaade til fremstilling af 5-methyl-isoxazol-4-carboxylsyreanilider
DK146205C (da) Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater
DK156776A (da) Fremgangsmade til fremstilling af carbostyrilderivater
DK320276A (da) Fremgangsmade til fremstilling af 2-substituerede oxazolpyridiner
DK148139C (da) Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK528976A (da) Fremgangsmade til fremstilling af indazolderivater
DK324176A (da) Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater
DK387876A (da) Fremgangsmade til fremstilling af oxazolidinoner
DK433076A (da) Fremgangsmade til fremstilling af basisk substituerede pyridincarboxamider
DK146629C (da) Analogifremgangsmaade til fremstilling af depotsteroidestere
DK383476A (da) Fremgangsmade til fremstilling af 2-substitueret benzanilid
DK137275C (da) Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
DK565676A (da) Fremgangsmade til fremstilling af klavamderivater
DK137957B (da) Analogifremgangsmåde til fremstilling af 2-substituerede 5-fluorpyrimidin-4-oner.
DK127976A (da) Fremgangsmade til fremstilling af thiazolinonderivater
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK251176A (da) Fremgangsmade til fremstilling af cyklopropanolderivater
DK343976A (da) Fremgangsmade til fremstilling af 5-androsten-17-on-derivater
DK551076A (da) Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin
DK253676A (da) Fremgangsmade til fremstilling af cycloheptathiopenderivater
DK162976A (da) Fremgangsmade til fremstilling af heterocycliske forbindelser
DK142845C (da) Analogifremgangsmaade til fremstilling af imidazolderivater
DK141532C (da) Fremgangsmaade til fremstilling af 21-hydroxy-16-pregnen-20-onderivater

Legal Events

Date Code Title Description
ATS Application withdrawn